A fuzzy ZE-number group decision-making framework using BWM and MABAC for risk assessment in medicinal plant extraction

The extraction of bioactive compounds from medicinal plants is a crucial process in pharmaceutical and herbal medicine industries, yet it presents numerous challenges that can compromise quality, efficiency, and standardization. This study integrates Failure Mode and Effects Analysis (FMEA) with an advanced multi-criteria decision-making framework based on ZE-numbers, employing the ZE-based Best-Worst Method (ZE-BWM) to determine the relative importance of risk criteria and the ZE-MABAC method to rank the most critical risks in medicinal plant extraction. By incorporating decision makers' assessments, fuzzy logic, and reliability factors, this study enhances traditional risk assessment approaches by accounting for uncertainty and expert reliability, leading to a more precise decision-making framework. The findings indicate that sample contamination, improper handling, suboptimal extraction conditions, and instrumental calibration errors are the most significant failure modes affecting extraction efficiency and product quality. Sample-related risks, such as inconsistencies in raw material quality and contamination, can lead to variability in bioactive compound concentrations. Similarly, inefficient extraction techniques and poor solvent selection impact the purity and yield of the final product, while instrumental errors and inadequate calibration introduce measurement inconsistencies. To mitigate these risks, process standardization, rigorous quality control, and personnel training are essential. Additionally, integrating real-time monitoring systems, sustainable extraction techniques, and AI-driven predictive models can further enhance extraction reliability and efficiency. This research advances risk assessment methodologies by offering a structured and data-driven framework for optimizing medicinal plant extraction, ensuring consistency, and improving product quality. Future studies should focus on automation, real-time risk monitoring, and green extraction technologies to further enhance extraction processes.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-02-24
DOI
https://doi.org/10.1371/journal.pone.0342976
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A fuzzy ZE-number group decision-making framework using BWM and MABAC for risk assessment in medicinal plant extraction

Mohammad Reza Maghami, Salar Hafez Ghoran, Fatemeh Gheytasi, Saeid Jafarzadeh Ghoushchi et al.
PLoS ONE
Computational Drug Discovery Methods
article

A fuzzy ZE-number group decision-making framework using BWM and MABAC for risk assessment in medicinal plant extraction

Mohammad Reza Maghami, Salar Hafez Ghoran, Fatemeh Gheytasi, Saeid Jafarzadeh Ghoushchi, Masoumeh Kianifard, Mazlan Mohamed
article en

Abstract

The extraction of bioactive compounds from medicinal plants is a crucial process in pharmaceutical and herbal medicine industries, yet it presents numerous challenges that can compromise quality, efficiency, and standardization. This study integrates Failure Mode and Effects Analysis (FMEA) with an advanced multi-criteria decision-making framework based on ZE-numbers, employing the ZE-based Best-Worst Method (ZE-BWM) to determine the relative importance of risk criteria and the ZE-MABAC method to rank the most critical risks in medicinal plant extraction. By incorporating decision makers' assessments, fuzzy logic, and reliability factors, this study enhances traditional risk assessment approaches by accounting for uncertainty and expert reliability, leading to a more precise decision-making framework. The findings indicate that sample contamination, improper handling, suboptimal extraction conditions, and instrumental calibration errors are the most significant failure modes affecting extraction efficiency and product quality. Sample-related risks, such as inconsistencies in raw material quality and contamination, can lead to variability in bioactive compound concentrations. Similarly, inefficient extraction techniques and poor solvent selection impact the purity and yield of the final product, while instrumental errors and inadequate calibration introduce measurement inconsistencies. To mitigate these risks, process standardization, rigorous quality control, and personnel training are essential. Additionally, integrating real-time monitoring systems, sustainable extraction techniques, and AI-driven predictive models can further enhance extraction reliability and efficiency. This research advances risk assessment methodologies by offering a structured and data-driven framework for optimizing medicinal plant extraction, ensuring consistency, and improving product quality. Future studies should focus on automation, real-time risk monitoring, and green extraction technologies to further enhance extraction processes.

PLoS ONEVol. 21(2)
Urmia University of Technology (IR), Asia Pacific University of Technology & Innovation (MY), Technical University of Malaysia Malacca (MY), University of Malaya (MY), North Carolina Agricultural and Technical State University (US)
Openalex Percentile: Top 44%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.